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ABSTRACT
Recent observations in Portugal of a remarkable incidence (65%) of Salmonella isolates from several
sources (predominantly human and poultry) with decreased susceptibility to nitrofurantoin
(MIC ‡64 mg ⁄L), mostly comprising serogroup D isolates of Salmonella Enteritidis belonging to
different phage types, suggest that illegal use of nitrofurans, especially in the poultry industry, might
have contributed to the selection and prevalence of S. Enteritidis in food animals, and consequently to
human salmonellosis in Portugal. Indiscriminate use of nitrofurans might also be implicated in the
emergence of two multiresistant Salmonella Typhimurium clones disseminated throughout the country.
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Intensive animal production has led to a signiﬁ-
cant increase in the use of antimicrobial agents for
therapeutic, prophylactic and growth promotion
purposes in the veterinary ﬁeld. Any use of
antimicrobial agents is a public health concern
because of the resulting development, selection
and spread of resistance, and the persistence of
potentially harmful antimicrobial feed additives
in food animal products [1]. Of special concern is
the effect of such agents on the selection of
particular strains of bacteria implicated in human
infections. Consequently, EU member states are
required to implement programmes for monitor-
ing zoonoses and zoonotic agents [2], and existing
EU legislation concerning food hygiene and con-
trol of zoonoses includes a number of provisions
that seek to control speciﬁed foodborne zoonotic
agents that contaminate foodstuffs, including
Salmonella [3].
Nitrofurans are a large group of compounds
that are characterised by a nitro group at position
5 of the furan ring. The most important members
of this group include furaltadone, nitrofurantoin,
nitrofurazone and furazolidone [4]. Nitrofurans
have been used widely in veterinary medicine
because of their broad antimicrobial activity, as
well as in human medicine for speciﬁc indications
[4,5]. Several toxicological studies have reported
genotoxic and carcinogenic properties of the
nitrofuran drugs, and have established a risk to
human health from the occurrence of toxic resi-
dues in food products [5]. Consequently, furalt-
adone, nitrofurantoin and nitrofurazone were
banned from use in food animal production in
the EU in 1993 [6], and the use of furazolidone
was similarly prohibited in 1995 [7].
In 2002, a new method for detecting nitrofuran
residues, with a greater sensitivity and speciﬁcity
for detection of these compounds in food animal
products, was introduced in Portugal and other
European countries. The increase in the sensitiv-
ity of detection led to the nitrofurans crisis in
Portugal during 2002–2003, with evidence of
illegal abuse of these compounds, mainly in
poultry production farms [5].
Salmonella is one of the major causes of food-
borne disease in humans in Europe, and is
associated mainly with the consumption of con-
taminated poultry meat and products [8]. The
most frequently reported serotypes involved in
human salmonellosis in the EU in 2002 were
Salmonella Enteritidis (67%) and Salmonella
Typhimurium (17%) [8]. S. Enteritidis is wide-
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spread in poultry production throughout Europe,
including in Portugal, where one study showed
that 44% of Salmonella isolates from poultry
samples were of the S. Enteritidis serotype [9].
In contrast, S. Typhimurium has a more ubiquit-
ous host range, and is associated with pigs and
cattle as well as poultry [10].
Salmonella is naturally susceptible to nitrofu-
rans [11], but a study of 1183 non-typhoid
Salmonella isolates from human and non-human
sources (867 human clinical isolates, 98 isolates
from poultry products, 122 isolates from other
food types, 38 isolates from unknown food
sources and 58 isolates from the environment)
collected in Portugal during 2002–2003 revealed a
remarkable proportion of isolates (65%) with
decreased susceptibility to nitrofurantoin
(MIC ‡64 mg ⁄L), as determined by the agar
dilution method [12] (Table 1). The strain collec-
tion was obtained from the National Centre of
Salmonella (INSA, Lisboa, Portugal) and from
geographically dispersed clinical and food micro-
biology laboratories. The serotypes and phage
types were determined at the National Centre of
Salmonella. Resistance to other antimicrobial
agents was also observed (31% nalidixic acid,
19% tetracycline, 18% streptomycin, 17% sulpha-
methoxazole, 17% ampicillin, 9% chlorampheni-
col, 7% trimethoprim, 1% gentamicin and 0.2%
kanamycin) [13]. Different rates of resistance to
nitrofurantoin were observed in isolates from
poultry (n = 65 ⁄ 98; 66%) and in clinical isolates
from humans (n = 618 ⁄ 867; 71%) as compared
with isolates from food products other than
poultry (n = 50 ⁄ 122; 41%) and from the environ-
ment (n = 12 ⁄ 58; 21%). Decreased susceptibility
to nitrofurantoin was most common among sero-
group D isolates, mainly S. Enteritidis, which is
the serotype associated most frequently with
human infection in Europe [14]. In humans, 90%
of isolates with decreased susceptibility to nitro-
furantoin belonged to serogroup D, mainly
S. Enteritidis (26 phage types among 385 isolates
tested). Similarly, in poultry, 83% of isolates with
decreased susceptibility to nitrofurantoin be-
longed to serogroup D, mainly S. Enteritidis
(seven phage types among 14 isolates tested,
which were also observed among the human
isolates). Nitrofurantoin resistance in S. Enteritid-
is was more frequent than in other serogroups,
suggesting that illegal use of nitrofuran agents in
poultry production may have contributed to the
high prevalence of S. Enteritidis in poultry and
consequently in human infection.
Previous ﬁndings have also suggested a link
between resistance to nitrofurans in human Sal-
monella isolates and the food chain. According to
Rampling et al. [15], the authorisation for veterin-
ary use of nitrofurans in the UK during the 1990s,
including in poultry husbandry, may have played
a role in the dissemination of S. Enteritidis PT4,
the organism responsible for the increase in
human salmonellosis in the UK. In contrast, all
S. Enteritidis isolates tested in Australia, where
the use of nitrofurans was phased out in the
poultry industry, were susceptible to nitrofurans.
Australia is a country that has not experienced an
increase in human infections involving S. Enterit-
idis, and where clinical cases have not been linked
to consumption of any particular food product
[16].
Interestingly, decreased susceptibility to nitro-
furantoin was also observed among S. Typhimu-
rium multiresistant isolates obtained from
geographically dispersed clinical and food
sources in Portugal. It is likely that illegal veter-
inary use of nitrofurans occurred in food animal
production units other than those producing
poultry (where use was detected by the Portu-
guese authorities [5]), and that this may have
contributed to the emergence and persistence of
the two multiresistant S. Typhimurium clones
that are widespread in Portugal: one carrying a
2000-bp integron with blaoxa-30-aadA1 [17], and the
S. Typhimurium DT104 clone carrying 1000-bp
(aadA2) and 1200-bp (blaPSE-1) class 1 integrons
[13].
These observations highlight another problem
related to antibiotic usage in food animal produc-
tion, in that the widespread use of nitrofurans
might also be involved in the selection and
persistence of Salmonella in animals used for food
production. As a consequence, the intensive
Table 1. MICs of nitrofurantoin for Salmonella isolates
from different sources
Source n
No. of isolates with nitrofurantoin MIC (mg ⁄L) of
4 8 16 32 64 128 >128
Clinical (human) 867 2 8 43 196 477 137 4
Poultry 98 0 0 7 25 58 8 0
Other foods 122 1 6 26 39 43 6 1
Unknown foods 38 0 1 6 9 17 5 0
Environment 58 0 1 22 23 6 6 0
Escherichia coli ATCC 25922 was used as a reference strain (MIC 8 mg ⁄L).
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use of nitrofurans in Portugal, especially in the
poultry industry, might have favoured a high
incidence of S. Enteritidis in humans and inﬂu-
enced the emergence of the two multiresistant
S. Typhimurium clones that are disseminated
throughout the country. The use of antimicrobial
agents in food animal production should be
strongly discouraged because of the public health
risks associated with the development, selection
and spread of resistance.
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